Abcellera Biologics Stock Performance

Abcellera Biologics Relative Risk vs. Return Landscape

If you would invest  537.00  in Abcellera Biologics on November 1, 2025 and sell it today you would lose (159.00) from holding Abcellera Biologics or give up 29.61% of portfolio value over 90 days. Abcellera Biologics is currently does not generate positive expected returns and assumes 4.3385% risk (volatility on return distribution) over the 90 days horizon. In different words, 38% of stocks are less volatile than Abcellera, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.Given the investment horizon of 90 days Abcellera Biologics is expected to under-perform the market. In addition to that, the company is 5.77 times more volatile than its market benchmark. It trades about -0.11 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.08 per unit of volatility.

Abcellera Biologics Target Price Odds to finish over Current Price

Given the investment horizon of 90 days the stock has the beta coefficient of 2.38 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Abcellera Biologics will likely underperform. Additionally Abcellera Biologics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.

Predictive Modules for Abcellera Biologics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Abcellera Biologics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 0.19 3.71 8.05 Details

Intrinsic Valuation Low Real High 0.86 5.20 9.54 Details

Naive Forecast Low Next High 0.07 3.28 7.62 Details

9 Analysts Consensus Low Target High 8.95 9.83 10.91 Details

Abcellera Biologics Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Abcellera Biologics is not an exception. The market had few large corrections towards the Abcellera Biologics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Abcellera Biologics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Abcellera Biologics within the framework of very fundamental risk indicators.

Abcellera Biologics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Abcellera Biologics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Abcellera Biologics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

Abcellera Biologics Price Density Drivers

Abcellera Biologics Fundamentals Growth

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abcellera Biologics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. For more information on how to buy Abcellera Stock please use our How to buy in Abcellera Stock guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abcellera Biologics. If investors know Abcellera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Abcellera Biologics assessment requires weighing all these inputs, though not all factors influence outcomes equally.

Understanding Abcellera Biologics requires distinguishing between market price and book value, where the latter reflects Abcellera's accounting equity. The concept of intrinsic value—what Abcellera Biologics' is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Abcellera Biologics' price substantially above or below its fundamental value.

Understanding that Abcellera Biologics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Abcellera Biologics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Abcellera Biologics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.